A new study examining real-world hospital data reveals early indicators of who is most likely to benefit from Cobenfy, the ...

Cobenfy, the first new schizophrenia drug in 50 years, offers early insights that could pave the way for more personalized ...

The Grammy winning singer and actress candidly admitted she was on a drug commonly prescribed to treat bipolar disorder while ...

Yung Lean spoke about his relationship with Ye (formerly Kanye West) and Travis Scott in a new interview with The New York ...

Millions of Americans with anxiety and depression struggle to find the right medication. The best fit may depend on your ...

A decade ago, the Swedish rapper was an internet sensation finding global fame. After struggling with drugs, he’s back with ...

Fast Coverage Without the Physical ...

The U.S. Food and Drug Administration named Richard Pazdur, its longtime overseer of cancer therapies, as its top drug ...

While Netizens blame Regina for marrying a man far older than her because of his wealth, Ned himself admitted that he wanted ...

Positive topline results announced from Phase 2a clinical trial of RAP-219 in patients with focal onset seizures Phase 2 trial of RAP-219 in ...

G rab your sleeping bags and bug spray, people. It’s time for camp. Chess is back on Broadway after 37 years, as big and ...

BD2 is a $100+ million initiative dedicated to funding and advancing research to improve the lives of people living with bipolar disorder. "This is a very ambitious project," said principal ...